A detailed history of Gamma Investing LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 487 shares of EOLS stock, worth $7,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares
487
Previous 478 1.88%
Holding current value
$7,957
Previous $6.69 Million 21.04%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$10.45 - $13.76 $94 - $123
9 Added 1.88%
487 $5.28 Million
Q1 2024

Apr 05, 2024

BUY
$9.99 - $14.91 $879 - $1,312
88 Added 22.56%
478 $6.69 Million
Q4 2023

Feb 01, 2024

BUY
$7.6 - $10.53 $2,964 - $4,106
390 New
390 $4.95 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $917M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.